CompletedPhase 4NCT01211327

Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda

Studying Vernal keratoconjunctivitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University Hospital, Ghent
Principal Investigator: Philippe Kesteleyn, MD, PhD
University Hospital, Ghent
Intervention: Cyclosporine A(drug)
Enrollment: 366 target
Eligibility: 5 years · All sexes
Timeline: 2008 – 2008

Study locations (1)

Kabgayi Hospital, Gitarama/Muhanga, Rwanda

Collaborators

Funds for Research in Ophthalmology (FRO) of Belgium · Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01211327 on ClinicalTrials.gov

Other trials for Vernal keratoconjunctivitis

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGNCT06913790
Evaluation of Central Corneal Thickness in Patients With Vernal Keratoconjunctivitis Using Topical Steroids
Superior University

See all trials for Vernal keratoconjunctivitis →

← Back to all trials